Cognitive Behavioural Therapy for Anxiety Disorders in PD

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Parkinson's DiseaseGeneralized Anxiety DisorderSocial Phobia
Interventions
BEHAVIORAL

Cognitive Behavioural Therapy (CBT)

Cognitive Behavioural Therapy (CBT) is considered the gold standard in psychotherapeutic treatments of anxiety. CBT is defined as: 'An amalgam of behavioural and cognitive problem-based interventions guided by principles of applied science. The behavioural interventions aim to decrease maladaptive behaviours and increase adaptive ones by modifying their antecedents and consequences and by behavioural practices that result in new learning. The cognitive interventions aim to modify maladaptive cognitions, self-statements, or beliefs.' (Arch \& Craske, 2009; Craske, 2010).

OTHER

Clinical monitoring

Patients assigned to clinical monitoring only will receive general education material on coping with PD symptoms and behavioural symptoms such as anxiety. In addition, they will be followed-up 1 month after baseline assessment via telephone calls to inquire about current anxiety symptoms. Patients will remain under the care of their personal physicians, who will also monitor their medical and psychiatric status.

Trial Locations (2)

59037

Neurology and Movement Disorders Unit, Lille University Hospital, Lille

6202 AZ

Maastricht University Medical Centre, Maastricht

All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

Maastricht University Medical Center

OTHER

NCT02648737 - Cognitive Behavioural Therapy for Anxiety Disorders in PD | Biotech Hunter | Biotech Hunter